Parallel
PrivateLast Round
Series A
Mar 19, 2026
Total Funding Raised
$25.35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Parallel operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in March 2026.
Parallel is a healthcare AI company that develops vertical AI agents to automate administrative workflows in hospitals, such as medical coding.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Workflow Automation, Revenue Cycle, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parallel Comparables
Compare Parallel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tennr | 46% | |
| Keragon | 45% | |
| calliora | 44% |
For institutional investors. Book with your work email.
Parallel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 19, 2026 | ||||
| Seed | Apr 3, 2025 | ||||
| Pre Seed | Aug 29, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Parallel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Seed |
| Frazier Group | Pre Seed |
| Convoi Ventures | Pre Seed |
| Penny Jar Capital | Pre Seed |
| Hexa | Series A |
| Y Combinator | Series A, Seed |
| Better Angle | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 66% MoM, reaching 7.9K.
- Jul 17, 2026
Grew 47% QoQ, from 15 to 22 employees.
For institutional investors. Book with your work email.
Parallel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Parallel's valuation, stock price, and market status.
Is Parallel a public or private company?
Parallel is a private company.
What is the current stock price of Parallel?
Parallel is a private company, so its shares have no public market price. Caplight tracks Parallel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Parallel worth (valuation)?
Valuation information for Parallel is not publicly available.
Can I buy Parallel stock?
Parallel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Parallel's last funding round?
Parallel's most recent funding round was Series A on March 19, 2026.
Who are the main investors in Parallel?
Key investors in Parallel include Penny Jar Capital, Index Ventures, Frst Capital.
Will Parallel IPO soon?
No public IPO plans have been announced for Parallel.
How can I track Parallel secondary market activity?
Caplight tracks bids, offers, and trades in Parallel's shares on secondary markets.